Dietary Supplementation of Lactogyn in Women With Bacterial Vaginosis

Status Completed

Clinical Trial Summary

The objective of the study is to determine clinical efficacy of Lactogyn (Lactobacillus Crispatus, L. brevis, L.acidophilus) in prevention of recurrent BV

Clinical Trial Description

According to classification, this is a phase 2 randomized parallel group prospective controlled dietary study to evaluate efficacy of a dietary supplement, a combination of L. crispatus LMG S-29995, L. brevis, and L. acidophilus in women aged from 18 through 45 years suffering from rBV. The 2 phase of the study has been ascribed as there is no evidence that oral capsules with L. crispatus LMG S-29995, L. brevis, and L. acidophilus have a potential efficacy in rBV.

Qualifying women received a combination of the three probiotic strains with a half daily recommended dose of vitamin C or just vitamin C without probiotics, a control supplementation, via oral route of administration for up to 120 days. During the intake of active or control formulations, participants kept a structured 120-DSD, where they recorded test capsules intake, screen for symptoms of bacterial vaginosis, and food intolerance events.

Based on repeat physical examination with application of Amsel and Nugent criteria the main conclusions over the efficacy of probiotic strains were made. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03601429
Study type	Interventional
Source	Vesale Pharmaceutica
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2018
Completion date	August 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03930745` - Suppression Of Bacterial Vaginosis (BV) [SUBVert]	Phase 2
Completed	`NCT02863536` - A Study of the New Medical Device Polybactum®	N/A
Completed	`NCT03187457` - PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"	N/A
Recruiting	`NCT02185456` - Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis	Phase 0
Completed	`NCT02150655` - Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women	Phase 0
Completed	`NCT01450462` - Vitamin D and Sexual Health	N/A
Recruiting	`NCT01558388` - Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy	Phase 4
Completed	`NCT01471457` - Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis	Phase 2/Phase 3
Not yet recruiting	`NCT00889356` - Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis	Phase 3
Completed	`NCT00545181` - Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial	N/A
Completed	`NCT00556179` - Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis	Phase 4
Completed	`NCT02236156` - Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)	Phase 3
Not yet recruiting	`NCT05434104` - The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study	N/A
Completed	`NCT01335373` - Observational Program Neo-Penotran® Forte	N/A
Completed	`NCT00752193` - Safety and Efficacy of a Vaginally Administered Probiotic Lactobacilli Delivery System.	N/A
Active, not recruiting	`NCT00536848` - The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients	Phase 2/Phase 3
Completed	`NCT00510614` - Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study	Phase 0
Suspended	`NCT00207480` - Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young Women	Phase 1
Recruiting	`NCT05278130` - Serial Screening and Treatment of Bacterial Vaginosis Trial	N/A
Completed	`NCT02905890` - The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis	Phase 4